OTC Regulation Ripple Effect

Alex McDonald, CEO, Wholesale Market Brokers Association

Over-the-counter (OTC) derivatives emerged from the financial crisis with a tarnished reputation. Derivatives came to embody the highly leveraged risk-spreading of the years leading up to the 2008 market downturn, so it’s no surprise that regulators on both sides of the Atlantic are pushing for OTC derivatives to be shunted onto more stringently regulated public trading platforms.

The argument goes that by improving the availability of information, enhanced transparency will improve the price

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: